Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that by 2019 the acute gout drug market will triple in size to $117 million and the chronic gout drug market will reach $1.83 billion.
By 2019, the acute gout drug market will triple in size while the chronic gout drug market will reach $1.83 billion